Thank you for donating!
You can donate using the following services.
Donate Today
Search
Need support today?
Email: info@npuk.org
Helpline: 0191 415 0693
Main menu
Niemann-Pick Diseases
About Us
Care & Support
Research
Fundraising
Resources
Blog
News
NPUK Shop
COVID-19
News
NPUK
>
News
21.12.23
Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled
Read more
19.12.23
Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
Read more
08.12.23
Celebrating The Hollie Foundation
Read more
11.10.23
Zevra Therapeutics Welcomes Neil F. McFarlane as President and CEO
Read more
22.09.23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
Read more
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next
Clinical Trials
CTD Holdings Inc
IntraBio
News
NPUK Annual Family Conference
NPUK News
Orphazyme
Sanofi Genzyme
The Quinn Madeline Foundation
Uncategorized
Donate today
Follow NPUK
Contact us
Donate today
Email: info@npuk.org
Helpline: 0191 415 0693